Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Company Information
About this company
Key people
Christopher A. Simon
President, Chief Executive Officer, Director
James C. D'Arecca
Executive Vice President, Chief Financial Officer
Frank W. Chan
Chief Operating Officer, Executive Vice President
Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Michelle L. Basil
Executive Vice President, General Counsel
Roy Galvin
Executive Vice President, Chief Commercial Officer
Olga Guyette
Vice President, Investor Relations & Treasury
Ellen M. Zane
Independent Chairman of the Board
Robert E. Abernathy
Independent Director
Diane M. Bryant
Independent Director
Michael J. Coyle
Independent Director
Charles J. Dockendorff
Independent Director
Click to see more
Key facts
- Shares in issue46.81m
- EPICHAE
- ISINUS4050241003
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$3.18bn
- Employees3,023
- ExchangeNew York Stock Exchange
- IndexS&P 400 Mid Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.